Fiche centre
GSK Investigational Site
Cologne — Germany
Essais liés3clinical trials
VilleColognelocalisation
PaysGermanylocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT01772199
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| GSK4527226 | Alzheimer | Phase 2 | NCT06079190 | PROGRESS-AD — Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease | TERMINATED |
| GSK239512 | SEP | Phase 2 | NCT01772199 | Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis | COMPLETED |
| Belimumab | Myasthénie | Phase 2 | NCT01480596 | The Evaluation of Belimumab in Myasthenia Gravis (MG) | COMPLETED |